Safe Use of NSAIDs and Gabapentin

Introduction to NSAID and Gabapentin Combinations

• Combining gabapentin with two NSAIDs (e.g., celecoxib and meloxicam) increases the risk of sedation and CNS depression, particularly in elderly patients 1
• The combination of opioids with gabapentinoids increases the risk of respiratory depression, with elderly patients being particularly vulnerable to these effects 1, 2

Choosing Appropriate Medication Combinations

• The American Geriatrics Society recommends choosing a single NSAID (e.g., celecoxib or meloxicam) to minimize adverse effects 1
• A multimodal approach for pain management involves combining a single NSAID with gabapentin, which may have synergistic effects for neuropathic pain 3
• Acetaminophen can be used with gabapentin as a non-NSAID alternative if NSAIDs are contraindicated, and topical analgesics can be considered to reduce systemic exposure 3

Monitoring and Managing Risks

• Elderly patients are at higher risk of adverse effects from NSAIDs, and the lowest effective dose of a single NSAID should be used for the shortest duration 2
• Monitor renal function, blood pressure, and signs of GI bleeding when using NSAIDs, and consider gastroprotection with proton pump inhibitors for patients with GI risk factors 2
• For patients with cardiovascular disease, NSAID use should be limited to 30 days, and alternatives should be considered, while patients with renal impairment require close monitoring of renal function and may need dose adjustments 2
• The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) recommends limiting COX-2 inhibitors like celecoxib to 30 days in patients with high cardiovascular risk, using the lowest effective dose for the shortest duration possible to minimize cardiovascular, gastrointestinal, and renal risks 4
• Celecoxib increases the risk of thrombotic cardiovascular events, including myocardial infarction and stroke, particularly in patients with elevated cardiovascular risk 5

Cardiovascular Risk Management

• Evaluate the patient's cardiovascular, gastrointestinal, and renal risk before prescribing celecoxib, considering factors such as age (especially >65 years) 4
• The risk of cardiovascular events increases with advanced age, hypertension, and concomitant use of low-dose aspirin 5
• The American College of Gastroenterology and other guidelines suggest using the lowest effective dose of celecoxib (generally 100-200 mg/day) for the shortest duration possible, especially in patients with cardiovascular or gastrointestinal risk factors 6
• For patients with high cardiovascular risk, treatment should be limited to 30 days, according to the ESCEO guidelines 4
• Consider alternative treatments such as topical NSAIDs or non-NSAID analgesics for patients with high cardiovascular risk 4

Gastrointestinal Risk Management

• Risk factors for gastrointestinal complications include a history of peptic ulcer, advanced age, and concomitant use of corticosteroids or anticoagulants 6
• Consider gastric protection with proton pump inhibitors in patients with gastrointestinal risk 6
• Celecoxib has a lower risk of gastrointestinal complications compared to non-selective NSAIDs, but this benefit is lost when used concomitantly with low-dose aspirin 6

Renal Risk Management

• Patients with renal impairment require close monitoring of renal function and may need dose adjustments 2
• The use of celecoxib is associated with an increased risk of renal dysfunction, and patients should be monitored for signs of renal impairment 7, 5

Special Populations

• Elderly patients (>65 years) are at substantially higher risk for NSAID-associated adverse events, and the lowest effective dose should be used with close monitoring 8, 9
• Patients with liver disease should use acetaminophen with extreme caution or avoid entirely, according to the National Comprehensive Cancer Network 10
• Patients with compromised renal function should use both acetaminophen and NSAIDs with caution, as recommended by the MMWR Recommendations and Reports 11

Medication Management

• The following table summarizes the risks associated with celecoxib use:

• Monitor for signs of cardiovascular events, GI bleeding, and renal dysfunction, and provide gastroprotection with proton pump inhibitors if necessary, with the American College of Cardiology recommending using the lowest effective dose of NSAIDs for the shortest possible duration to minimize risks 7, 5
• The American Heart Association recommends careful monitoring and management of fluid balance, with salt restriction and weight monitoring, and consideration of medications like ACE inhibitors/ARBs, beta-blockers, and diuretics, with caution due to risk of hypotension, and a strength of evidence of moderate to high 12
• ACE inhibitors/ARBs should be used at the lowest effective dose with caution due to risk of hypotension, as recommended by the American Heart Association, with a strength of evidence of moderate to high 12
• Beta-blockers should be used cautiously as cardiac output may be heart rate dependent, according to the American College of Cardiology, with a strength of evidence of moderate 13